Beaird Harris Wealth Management’s Editas Medicine EDIT Stock Holding History

Beaird Harris Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-80	Closed	-$102	–	517
2024 Q4	$102	Hold	80	–	–	﹤0.01%	495
2024 Q3	$273	Hold	80	–	–	﹤0.01%	498
2024 Q2	$374	Hold	80	–	–	﹤0.01%	638
2024 Q1	$594	Hold	80	–	–	﹤0.01%	583
2023 Q4	$811	Hold	80	–	–	﹤0.01%	537
2023 Q3	$624	Hold	80	–	–	﹤0.01%	412
2023 Q2	$659	Hold	80	–	–	﹤0.01%	416
2023 Q1	$580	Hold	80	–	–	﹤0.01%	436
2022 Q4	$710	Sell	80 -373	-82%	-$4.09K	﹤0.01%	665
2022 Q3	$6K	Hold	453	–	–	﹤0.01%	325
2022 Q2	$5K	Hold	453	–	–	﹤0.01%	306
2022 Q1	$9K	Buy	453 +296	+189%	+$5.5K	﹤0.01%	341
2021 Q4	$4K	Buy	+157	New	+$5.4K	﹤0.01%	489

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Beaird Harris Wealth Management's EDIT Position: Q1 2025 in Review

Beaird Harris Wealth Management sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 80 shares — an estimated $102 sold.

Beaird Harris Wealth Management first reported a position in EDIT in Q4 2021 and held it in 13 quarters. The position peaked at $9K in Q1 2022. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

Beaird Harris Wealth Management reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
Beaird Harris Wealth Management sold 80 Editas Medicine shares in Q1 2025, an estimated $102.
Beaird Harris Wealth Management first reported a position in Editas Medicine in Q4 2021 and held it in 13 quarters.
Beaird Harris Wealth Management's Editas Medicine position peaked at $9K in Q1 2022.
194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Beaird Harris Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.